药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tazarotene
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Arsenic trioxide.
Tazarotene
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Arsenic trioxide.
Tazarotene
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Arsenic trioxide.
Tazarotene
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Arsenic trioxide.
Tazarotene
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Arsenic trioxide.
Tazarotene
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Arsenic trioxide.
Tazarotene
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Arsenic trioxide.
Tazarotene
Niguldipine
The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Arsenic trioxide.
Tazarotene
Efonidipine
The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Arsenic trioxide.
Tazarotene
Aranidipine
The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Arsenic trioxide.
Tazarotene
Dosulepin
The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Arsenic trioxide.
Tazarotene
Pinaverium
The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Arsenic trioxide.
Tazarotene
Trimebutine
The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Arsenic trioxide.
Tazarotene
Olodaterol
The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Arsenic trioxide.
Tazarotene
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Arsenic trioxide.
Tazarotene
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Arsenic trioxide.
Tazarotene
Dabrafenib
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Arsenic trioxide.
Tazarotene
Mirabegron
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Arsenic trioxide.
Tazarotene
Bupranolol
The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Arsenic trioxide.
Tazarotene
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Arsenic trioxide.